The 4th Annual Drug Discovery Congress 2017 brings together over 250 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. Novel strategies and technologies for drug discovery and medicinal chemistry will be discussed across 4 Interactive streams:

• Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
• Phenotypic Drug Discovery, High Throughput Technologies and RNAi Screening
• Discovery Chemistry: Medicinal and Computational Chemistry
• Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design

Domainex COO, Tom Mander will be chairing the Discovery Chemistry: Medicinal and Computational Chemistry stream.  We will also be exhibiting (booth #3), so why not come and talk with Tom and Chemistry Group Leader, Philip Fallon, to discuss how Domainex can support your next drug discovery programme?